A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Ukraine Hospital Improving Emergency Cardiovascular Care During National Crisis

Through ACC Global Quality Solutions Program, Dnipro hospital CV teams are enhancing skills and raising quality of care for local heart attack patients

The Clinical Hospital of Emergency Services, a municipal hospital serving the community of Dnipro, in Ukraine, is the first in the country to take part in the American College of Cardiology’s Global Quality Solutions program. The hospital in Ukraine joins the program in an effort to improve heart attack care by reducing heart attack related deaths and saving lives in their community.

“When the war started, myself and others on my team decided to stay at work to do our best to help our people, soldiers, neighbors and relatives to survive. But we decided it was not enough to only maintain, but that we must develop and raise our skills and quality of care,” said Anastasiya Skoromna, MD, PhD, Head of the Interventional Diagnostics and Percutaneous Treatment Department at the Clinical Hospital of Emergency Services in Dnipro, Ukraine. “Because, when the war ends, Ukraine will have a great need for the recovery of its systems and infrastructure. If we are ready, it will be an easier and faster recovery.”

ACC’s Global Quality Solutions program, in collaboration with Health Catalyst, works directly with hospitals around the world to collect data on cardiovascular procedures and identify specific opportunities to improve patient care and outcomes. As part of the program, the Clinical Hospital of Emergency Services will have access to data collection, analysis and reporting frameworks that leverage ACC’s NCDR CathPCI Registry data set.

According to the NCD Alliance, cardiovascular diseases account for 64% of all deaths from non-communicable diseases in Ukraine. This trend is compounded by the continued humanitarian crisis, which has displaced more than 12 million individuals of whom 2.63 million have cardiovascular disease.

“Ensuring access to essential cardiovascular care is more important than ever in Ukraine,” said ACC Immediate Past President Edward T.A. Fry, MD, MACC. “The Clinical Hospital of Emergency Services in Dnipro’s commitment to optimizing care and outcomes of patients with heart disease or related risk factors in the midst of unprecedented and unimaginable challenges—including a constant lack of supplies from basic syringes to interventional catheters and assist devices—is commendable, heroic and inspirational. It is truly an honor and privilege to support the hospital staff and clinicians in their quest to continue to transform cardiovascular care and improve heart health during this time.”

Skoromna’s team is made up of four interventional cardiologists ranging from newly practicing to longtime practitioners who are passionate about the work. The department opened at the end of 2021, shortly before the war began, making it even more difficult to start an interventional cardiology department where there hadn’t previously been one.

“The task was not only to start, but to integrate into the hospital system and then survive this war. We work 24/7 without weekends to provide care to our patients,” Skoromna said. “We have mostly acute coronary syndrome patients and late admissions. With such a diverse cohort of patients, being an interventional cardiologist is not enough. We need tools, supplies and what is most important—good and structured support.”

The Clinical Hospital of Emergency Services joins a growing list of hospitals around the world, including in South Africa, Brazil and Saudi Arabia, who are taking part in the Global Quality Solutions program and have a shared commitment to leveraging data and innovative technologies to proactively address the burden of cardiovascular disease within their own countries, as well as the rest of the world.

“Our hope is that by participating in the Global Quality Solutions program we will better be able to see the gaps in our care, so that we can learn how to deal with them and tune the health care system to work better,” Skoromna said. “The country worked for too long in post-Soviet order; we want and need to change it, once and forever, for the healthy future of our patients.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy